Analyst Ratings for Avalo Therapeutics Inc. (AVTX)
AVTX Rating Summary
AVTX Price Target Summary
- Highest: $60.00 (Piper Sandler)
- Lowest: $29.00 (Wedbush)
- Average: $41.64
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$41.64 (+115%)
* Over Last 12-Mos
Rating Score: 9.4 / 10
Percentile Rank: 90%
Rating Score: 9.4 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/6/2026 | Leerink | Thomas Smith | New Coverage | Outperform (N/A) |
38.00 (N/A) |
18.84 (19.37) |
2.81% | Details |
| 6/12/2026 | BofA Securities | Alec Stranahan | New Coverage | Buy (N/A) |
35.00 (N/A) |
13.67 (19.37) |
41.7% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
